Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018

Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018

Category : Healthcare
Published On : October  2014
Pages : 52


------------ Or -------------
About Preimplantation Genetic Diagnosis
Preimplantation genetic diagnosis (PGD) testing involves the identification of genetic defects in embryos. It is performed to identify single gene disorders such as Sickle Cell Anemia, Cystic Fibrosis, Huntington’s Disease, Hemophilia, Marfan’s Disease, Thalassemia, Muscular Dystrophy, Tay Sachs, and  Spinal Muscular Atrophy. PGD tests are generally carried out in cases of a known genetic defect, or in late age pregnancy, or in patients with a history of repeated miscarriages. PCR, FISH, CGH, and SNP are some of the common technologies used in PGD testing with PCR the most widely used.  FISH technology is beneficial in the determination of chromosomal abnormalities, X-linked diseases, and aneuploidy screening. CGH and SNP are advanced technologies, which have high accuracy in screening and diagnosis.
TechNavio's analysts forecast the Global Preimplantation Genetic Diagnosis market to grow at a CAGR of 6.30 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Preimplantation Genetic Diagnosis market for the period 2014-2018. To calculate the market size, the report considers revenue generated from sales of PGD services and products including kits and instruments used for PGD. 
TechNavio's report, the Global Preimplantation Genetic Diagnosis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preimplantation Genetic Diagnosis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
Key Vendors
• Genesis Genetics
• Laboratory Corporation of America 
• Reproductive Genetics Institute
• Reprogenetics 
Other Prominent Vendors
• Abbott Laboratories
• F. Hoffmann-La Roche
• Illumina 
• Natera
• PerkinElmer 
Market Driver
• Increasing Rate of Infertility
• For a full, detailed list, view our report
Market Challenge
• High Costs of PGD
• For a full, detailed list, view our report
Market Trend
• Growing Opportunity for Direct-to-Consumer Genetic Testing 
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
08. Geographical Segmentation
08.1 PGD Market in Americas
08.1.1 Market Size and Forecast
08.2 PGD Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 PGD Market in APAC Region
08.3.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2013
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Genesis Genetics
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Service Segmentation
17.1.4 SWOT Analysis
17.2 LabCorp
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation
17.2.4 Revenue Segmentation by Business
17.2.5 Revenue Comparison - 2012 and 2013
17.2.6 Key Developments:
17.2.7 SWOT Analysis
17.3 Reproductive Genetics Institute
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Service Segmentation
17.3.4 SWOT Analysis
17.4 Reprogenetics
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Service Segmentation
17.4.4 SWOT Analysis
18. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global PGD Market 2013-2018 (US$ million)
Exhibit 3: Global PGD Market Segmentation by Technology
Exhibit 4: Global PGD Market Segmentation by Geography 2013
Exhibit 5: PGD Market in Americas 2013-2018 (US$ million)
Exhibit 6: PGD Market in EMEA Region 2013-2018 (US$ million)
Exhibit 7: PGD Market in APAC Region 2013-2018 (US$ million)
Exhibit 8: Global PGD Market by Geographical Segmentation 2013-2018 (US$ million)
Exhibit 9: Global PGD Market by Geographical Segmentation 2013-2018
Exhibit 10: Genesis Genetics: Service Segmentation 2013
Exhibit 11: Business Segmentation of LabCorp
Exhibit 12: Revenue Segmentation of LabCorp 2013
Exhibit 13: Revenue Comparison of LabCorp by Business Segments (in US$ millions)
Exhibit 14: Reproductive Genetics Institute: Service Segmentation 2013
Exhibit 15: Reprogenetics: Service Segmentation 2013

Enquiry Before Buy